阿片类药物治疗慢性疼痛:失误、教训与未来方向
本文回顾了20世纪末以来阿片类药物治疗慢性疼痛的流行与教训,指出处方阿片类药物滥用已成美国流行病,其滥用和死亡主要发生在院外或临终关怀机构之外,涉及门诊慢性疼痛患者及药物转手。文章总结了相关失误与经验,并探讨未来慢性疼痛管理的方向。
要点
- 处方阿片滥用和死亡主要源于门诊慢性疼痛治疗,而非住院或临终关怀。
- 过度处方使易感个体获得高度成瘾性药物,并导致药物转手。
- 需从历史教训中重新审视慢性疼痛的阿片类药物使用策略。
核心结论
- 对阿片类药物的过度依赖是处方阿片滥用流行的根本原因,且滥用与死亡主要发生在门诊慢性疼痛治疗场景。
研究设计与样本
- 本文为综述,基于对历史统计和文献的回顾,分析阿片类药物治疗慢性疼痛的失误与教训。
主要发现
- 导致美国CDC宣布处方阿片滥用达到流行水平的统计显示,滥用事件和死亡发生在医院或临终关怀机构之外。
- 滥用和死亡既发生在慢性疼痛患者自身,也通过药物转手发生。
- 对门诊患者的过度处方使痛苦和脆弱的个体获得了这些高度成瘾性药物。
临床怎么用
- 慢性疼痛管理应吸取历史教训,减少对阿片类药物的过度依赖,关注门诊处方风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An overreliance on opioids has impacted all types of pain management, making it undoubtedly a root cause of the "epidemic" of prescription opioid abuse in the United States. Yet, an examination of the statistics that led the US Centers for Disease Control and Prevention to declare that prescription opioid abuse had reached epidemic levels shows that the abuse occurrences and deaths are arising outside the hospital or hospice setting, which strongly implicates the outpatient use of opioids to treat chronic pain. Such abuse and related deaths are occurring in chronic pain patients themselves and also through diversion. Overprescribing to outpatients has afforded distressed and vulnerable individuals access to these highly addictive drugs. The focus of this article is on what we have learned since opioid treatment of chronic pain was first popularized at the end of the 20th century and how this new information can guide chronic pain management in the future.
引用
- Ballantyne JC. Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions. Anesth Analg. 2017. PMID: 29049121. doi:10.1213/ANE.0000000000002500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。